BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:63303530-3562-4162-a135-313333626361
BEGIN:VEVENT
UID:74824039a7702fcef6ab3660559ce7d6f8fd7a2a@swoogo.com
DTSTAMP:20261008T002408Z
DESCRIPTION:Review AstraZeneca Oncology priority therapeutic areas with a p
 articular spotlight on prostate and hematology therapeutic areas\, future 
 directions for registered products and late-phase new molecular entities\,
  and discuss areas of interest for collaboration.
DTSTART:20250304T213000Z
DTEND:20250304T223000Z
LAST-MODIFIED:20261008T002408Z
LOCATION:
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:AstraZeneca Oncology Late Development Pipeline Overview
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p>Review AstraZeneca Oncology priority therap
 eutic areas with a particular spotlight on prostate and hematology therape
 utic areas\, future directions for registered products and late-phase new 
 molecular entities\, and discuss areas of interest for collaboration.</p>
BEGIN:VALARM
UID:36313061-3264-4234-b838-383338636430
ACTION:DISPLAY
DESCRIPTION:Review AstraZeneca Oncology priority therapeutic areas with a p
 articular spotlight on prostate and hematology therapeutic areas\, future 
 directions for registered products and late-phase new molecular entities\,
  and discuss areas of interest for collaboration.
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR